Cumberland Pharmaceuticals Inc.

CPIX Nasdaq SEC CIK 1087294
Follow Cumberland Pharmaceuticals Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $2.2M −74% vs same quarter last year
Net income $77.8M +4107.5% vs same quarter last year
EPS, diluted $5.07 +4000% vs same quarter last year
Operating cash flow −$1.5M −900.3% vs same quarter last year
Revenue by quarter
$10.4M
$11.7M
$10.8M
$8.3M
$13.7M
$9.1M
$8.8M
$2.2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$20M$0$20M$40M$60MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$44.5M−$2.8M
FY24$37.9M−$6.5M
FY23$39.6M−$6.3M
FY22$42M−$5.6M
FY21$35M−$3.5M
FY20$35.8M−$3.3M
FY19$32.4M−$3.5M
FY18$28.8M−$7M
FY17$25.5M−$8M
FY16$32.5M−$944.7K
FY15$900K$731.4K
FY14$600K$2.4M
FY13$800K−$2.1M
FY12$700K$5.8M
FY11$51.1M$5.7M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−500%0%500%1000%1500%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2585%−6.3%−6.4%
FY2482.6%−17%−17.1%
FY2384.7%−24.2%−15.9%
FY2278.3%−13.6%−13.3%
FY2174.9%−21.9%−10%
FY2075.9%−17.8%−9.3%
FY1977.1%−28.7%−10.9%
FY1879.1%−38.8%−24.2%
FY1778.8%−34.8%−31.2%
FY1681.7%−4.4%−2.9%
FY15-123.5%81.3%
FY14-593.1%404%
FY13-−475.2%−263.1%
FY12-1259.7%834.6%
FY1189.5%19.3%11.1%
Free cash flowOperating cash flow minus capital expenditure
−$2.5M$0$2.5M$5M$7.5M$10MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$4.8M
FY24−$678.6K
FY23$5.8M
FY22$8.4M
FY21$6.2M
FY20$5.3M
FY19$2.8M
FY18$2.7M
FY17−$833.7K
FY16$438.6K
FY15$5.7M
FY14$6.5M
FY13$648.7K
FY12$6.7M
FY11$8.5M
Returned to shareholdersDividends paid and shares bought back
$0$2.5M$5M$7.5M$10MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$263.5K
FY24$579K
FY23$740.5K
FY22$1.1M
FY21$1.4M
FY20$1.9M
FY19$3.5M
FY18$2.9M
FY17$3.7M
FY16$2.5M
FY15$5.3M
FY14$4.3M
FY13$4.8M
FY12$8.1M
FY11$4.2M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Cumberland Pharmaceuticals
  • Healthcare median
−500%0%500%1000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearCumberland PharmaceuticalsHealthcare median
FY25−6.4%−30.6%
FY24−17.1%−47%
FY23−15.9%−58%
FY22−13.3%−80.4%
FY21−10%−71.8%
FY20−9.3%−62.2%
FY19−10.9%−46.2%
FY18−24.2%−49.6%
FY17−31.2%−45.9%
FY16−2.9%−36%
FY1581.3%−37.8%
FY14404%−35.5%
FY13−263.1%−37.1%
FY12834.6%−29.1%
FY1111.1%−27.9%